This is a review about TACI, based on 4 published articles (read how Labome selects the articles), using TACI antibody in all methods. It is aimed to help Labome visitors find the most suited TACI antibody.
TACI synonym: CD267; CVID; CVID2; IGAD2; RYZN; TACI; TNFRSF14B; transmembrane activator and CAML interactor; tumor necrosis factor receptor 13B; tumor necrosis factor receptor superfamily, member 13B

R and D Systems
goat polyclonal
  • IP; human
R and D Systems TACI antibody (R&D Systems, AF174) was used in immunoprecipitation on human samples. J Immunol (2015) ncbi
mouse monoclonal (165604)
  • Neut; human; 5 ug/ml
R and D Systems TACI antibody (R&D Systems, FAB1741P) was used in neutralization on human samples at 5 ug/ml. J Immunol (2015) ncbi
mouse monoclonal (165609)
  • IP; human
R and D Systems TACI antibody (R&D Systems, MAB174) was used in immunoprecipitation on human samples. J Immunol (2015) ncbi
mouse monoclonal (165604)
  • FC; human
R and D Systems TACI antibody (R&D Systems, FAB1741P) was used in flow cytometry on human samples. Blood (2009) ncbi
Abcam
rat monoclonal (1A1)
  • FC; human
Abcam TACI antibody (Abcam, 1A1) was used in flow cytometry on human samples. J Clin Immunol (2014) ncbi
not indicated
  • FC; human
Abcam monoclonal rat anti-human TACI antibody was used to carry out flow cytometry analysis in order to evaluate the genetic, immunologic, and clinical condition of patients with different TNFRSF13B variants.Blood (2009) ncbi
eBioscience
mouse monoclonal (11H3)
  • FC; human
eBioscience TACI antibody (eBiosciences, 11H3) was used in flow cytometry on human samples. J Clin Immunol (2014) ncbi
PeproTech
not indicated
  • FC; human
Peprotech EC biotinylated polyclonal goat anti-human TACI antibody was used to carry out flow cytometry analysis in order to evaluate the genetic, immunologic, and clinical condition of patients with different TNFRSF13B variants.Blood (2009) ncbi
Articles Reviewed
  1. Franziska S Hoffmann et al. (2015). "The immunoregulator soluble TACI is released by ADAM10 and reflects B cell activation in autoimmunity".PMID 25505277
  2. Rita R Barbosa et al. (2014). "Reduced BAFF-R and increased TACI expression in common variable immunodeficiency".PMID 24809296
  3. Mamta Gupta et al. (2009). "A proliferation-inducing ligand mediates follicular lymphoma B-cell proliferation and cyclin D1 expression through phosphatidylinositol 3-kinase-regulated mammalian target of rapamycin activation".PMID 19321861
  4. Ulrich Salzer et al. (2009). "Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes".PMID 18981294